Status:
COMPLETED
Football Players Health Study In Person Assessments Study
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Harvard Medical School (HMS and HSDM)
Beth Israel Deaconess Medical Center
Conditions:
Cardiac Dysfunction
Neurocognitive Disease
Eligibility:
MALE
24-55 years
Brief Summary
The aim of the Football Players Health Study (FPHS) is to advance the understanding of the complex and inter-related pathways that can develop into player related illness and disability. Former Nation...
Detailed Description
Little is known about the long term health impacts of being exposed to a career in professional football. The primary objective of this study is to assess the relationship between affliction definitio...
Eligibility Criteria
Inclusion
- Age 24-55 at the time of first Health and Wellness Questionnaire (Q1) completion.
- Former professional football player who played between 1960 to present.
- Prior completed the first Health and Wellness Questionnaire (Q1)
- "Healthy" subjects: ability to give informed consent and comply with study procedures.
- "Afflicted" participants: must meet criteria for at least one of the following subjective afflictions based on Q1 responses: 1) Cardiovascular Dysfunction, 2) Neurocognitive Disease, 3) Chronic Pain, and/or 4) Sleep Apnea
Exclusion
- Prior metallic device implants such as cardiac pacemakers/defibrillators or perfusion pumps that cannot be removed.
- Ferromagnetic implants or objects that cannot be removed such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants or jewelry
- Body weight \>390 lbs at screening
- Inability to complete the telephone screener
- Low T-MoCA score (\<17) and absence of an available study partner if required following MD review.
- Significant behavioral or functional disability due to cognitive impairment
Key Trial Info
Start Date :
April 22 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2022
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT03866564
Start Date
April 22 2019
End Date
November 30 2022
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114